Sean Murphy was most recently senior advisor at Evercore Partners, a leading investment banking advisory firm. Prior to Evercore, Mr. Murphy was the head of corporate M&A and business development at Abbott Laboratories. In a career that spans over thirty years, Mr. Murphy’s experience in the life sciences sector is both operational and transactional, having run Abbott’s vascular business and played a leading role in a number of strategic investments during his tenure. Mr. Murphy is a director of Malin Plc and a director and shareholder of Brandon Point Industries. He currently serves on the boards of Viamet, Novan, Altan, Xenex Disinfection Services, Brandon Point Industries and Immucor. Mr. Murphy holds a B.B.A. in business administration-finance from Western Illinois University and an M.S. in finance from the University of Illinois at Urbana-Champaign.